https://www.nature.com/articles/s41591-025-04154-z Addyi for Women Addyi, also known by its generic name flibanserin, is a medication approved for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. It is designed to help women who experience a persistent lack of sexual desire that causes distress or interpersonal difficulties. How It Works Addyi works by affecting neurotransmitters in the brain, particularly by increasing dopamine and norepineph

https://cardiovascularbusiness.com/topics/clinical/heart-health/how-recreational-adderall-use-affects-heart-cardiologists-warning Recreational Use of Adderall and Cardiology Risks Adderall, a prescription medication primarily used to treat Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy, is sometimes misused recreationally for its stimulant effects. This misuse can pose significant risks, particularly concerning cardiovascular health. Understanding Adderall A

https://www.nature.com/articles/s41591-025-04154-z DMT and Major Depressive Disorder What is DMT? DMT (N,N-Dimethyltryptamine) is a powerful psychedelic compound found in various plants and animals. It is known for inducing intense visual and auditory hallucinations and profound alterations in consciousness. Potential Benefits for Major Depressive Disorder Research into the therapeutic effects of psychedelics, including DMT, is gaining traction. Some potential benefits for

https://jamanetwork.com/journals/jamaneurology/fullarticle/2845746 Low Dose Lithium for Mild Cognitive Impairment Overview Low dose lithium has been explored as a potential treatment for mild cognitive impairment (MCI) due to its neuroprotective properties. MCI is a transitional stage between normal cognitive aging and more serious conditions like Alzheimer's disease. Mechanism of Action Lithium is known to: Enhance neurogenesis Stabilize mood Modulate neurotransmitter syst

Findings showed COMP360 psilocybin 25mg statistically significantly reduced symptom severity compared with the 1mg dose at week 6. Top line data were announced from a phase 3 study evaluating COMP360, a synthetic, proprietary formulation of psilocybin, in patients with treatment-resistant depression (TRD). The randomized, fixed repeat dose, double-blind phase 3 COMP006 study ( ClinicalTrials.gov Identifier: NCT05711940 ) evaluated the efficacy, safety, and tolerability of C

Depression affects millions worldwide, often resisting traditional treatments. Recent research points to synthetic psilocybin as a promising option for easing depressive symptoms. This blog post explores how synthetic psilocybin works, the science behind its effects, and what it could mean for people struggling with depression. ! Close-up view of synthetic psilocybin capsules on a white surface What Is Synthetic Psilocybin? Psilocybin is a naturally occurring compound found i

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2825809#google_vignette

https://www.sciencedaily.com/releases/2021/09/210909123905.html

https://www.sciencedaily.com/news/mind_brain/psychiatry/

https://www.sciencedaily.com/news/mind_brain/psychiatry/

https://www.sciencedaily.com/releases/2021/10/211012102657.html

https://www.sciencedaily.com/releases/2021/10/211027121940.html